3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Glioma
5
Glioblastoma
2
Brain Neoplasms
2
Stomach Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms
1
Multiple Myeloma
1
Mesothelioma
1
Meningeal Carcinomatosis
1
Melanoma
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid
1
Gliosarcoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Radiotherapy
122
Temozolomide
110
Carboplatin
53
Filgrastim
46
Vincristine
43
Etoposide
39
Cyclophosphamide
37
Chemotherapy, Adjuvant
37
Cisplatin
36
Carmustine
32
Irinotecan
27
Peripheral Blood Stem Cell Transplantation
25
Magnetic Resonance Spectroscopy
24
Lomustine
22
Thiotepa
21
Methotrexate
20
Granulocyte Colony-Stimulating Factor
18
Procarbazine
16
Bevacizumab
16
Surgical Procedures, Operative
15
O(6)-benzylguanine
14
etoposide phosphate
13
Drug Therapy
13
Topotecan
12
Paclitaxel
12
Ifosfamide
12
Thalidomide
11
Radiation
11
sargramostim
10
Specimen Handling
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Immunotherapy, Adoptive
×
CNS
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts